electroCore, Inc., a commercial-stage medical device company, is dedicated to the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is headquartered in Rockaway, New Jersey.
| Revenue (TTM) | $34.90M |
| Gross Profit (TTM) | $30.45M |
| EBITDA | $-14.28M |
| Operating Margin | -55.50% |
| Return on Equity | -478.70% |
| Return on Assets | -58.10% |
| Revenue/Share (TTM) | $4.04 |
| Book Value | $-0.70 |
| Price-to-Book | 34.89 |
| Price-to-Sales (TTM) | 1.59 |
| EV/Revenue | 1.604 |
| EV/EBITDA | 0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.60% |
| Shares Outstanding | $8.30M |
| Float | $5.22M |
| % Insiders | 37.19% |
| % Institutions | 9.18% |
Volatility is currently expanding